NCT00402311

Brief Summary

The purpose of this study is to determine the effects and cost-effectiveness of a Diagnostic Observation Center for PsychoGeriatric patients (DOC-PG). Our main hypothesis is that DOC-PG has added value compared with usual care regarding Health Related Quality of Life (HRQoL).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
216

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Apr 2002

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2002

Completed
3.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2005

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

November 20, 2006

Completed
2 days until next milestone

First Posted

Study publicly available on registry

November 22, 2006

Completed
Last Updated

January 22, 2007

Status Verified

November 1, 2006

First QC Date

November 20, 2006

Last Update Submit

January 19, 2007

Conditions

Delirium, Dementia, Amnestic, Cognitive DisordersMemory Disorders

Keywords

Health Services for the AgedGeriatric Psychiatry

Outcome Measures

Primary Outcomes (1)

  • The Visual Analogue Scale of the EuroQol-5D

Secondary Outcomes (9)

  • Utility score of the EuroQol-5D

  • Short Form 36 (SF-36)

  • Mini Mental State Examination (MMSE)

  • Global Deterioration Scale (GDS)

  • NeuroPsychiatric Inventory (NPI)

  • +4 more secondary outcomes

Interventions

DOC-PG: integrated multidisciplinary assessmentPROCEDURE
Usual care: assessment by GP or one of the regional servicesPROCEDURE

Eligibility Criteria

Age55 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aged 55 years or over
  • Suspected of having dementia or combined somatic/psychiatric disorder
  • No referral to other local/regional services in the last two years
  • Availability of a proxy (visiting the patient at least once a week)

You may not qualify if:

  • Acute disorders that need a prompt therapeutic intervention
  • Living in a nursing home or receiving care that is comparable to that of a nursing home

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Academic Hospital Maastricht

Maastricht, Limburg, 6202 AZ, Netherlands

Location

Related Publications (4)

  • Wolfs CA, Dirksen CD, Severens JL, Verhey FR. The added value of a multidisciplinary approach in diagnosing dementia: a review. Int J Geriatr Psychiatry. 2006 Mar;21(3):223-32. doi: 10.1002/gps.1454.

    PMID: 16440403BACKGROUND

  • Wolfs CAG, Severens JL, Dirksen CD, Kessels A, Jaspers N, Verhey FRJ. 2005. A Randomized Clinical Trial on the Effects of a Diagnostic Observation Centre for PsychoGeriatric patients (DOC-PG). International Psychogeriatrics 17: 370-371

    BACKGROUND

  • Wolfs CA, Verhey FR, Kessels A, Winkens RA, Severens JL, Dirksen CD. GP concordance with advice for treatment following a multidisciplinary psychogeriatric assessment. Int J Geriatr Psychiatry. 2007 Mar;22(3):233-40. doi: 10.1002/gps.1666.

    PMID: 16977677RESULT

  • Wolfs CA, Dirksen CD, Kessels A, Severens JL, Verhey FR. Economic evaluation of an integrated diagnostic approach for psychogeriatric patients: results of a randomized controlled trial. Arch Gen Psychiatry. 2009 Mar;66(3):313-23. doi: 10.1001/archgenpsychiatry.2008.544.

    PMID: 19255381DERIVED

Related Links

MeSH Terms

Conditions

Neurocognitive DisordersMemory Disorders

Condition Hierarchy (Ancestors)

Mental DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Frans R Verhey, PhD, MD

    Maastricht University Medical Center

    PRINCIPAL INVESTIGATOR

  • Carmen D. Dirksen, PhD

    Maastricht University Medical Center

    STUDY DIRECTOR

  • Johan L Severens, PhD

    Maastricht University Medical Center

    STUDY DIRECTOR

  • Alfons Kessels, MD, MSc

    Maastricht University Medical Center

    STUDY CHAIR

  • Claire A Wolfs, MSc

    Maastricht University Medical Center

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

November 20, 2006

First Posted

November 22, 2006

Study Start

April 1, 2002

Study Completion

August 1, 2005

Last Updated

January 22, 2007

Record last verified: 2006-11

Locations

NL(1)